Amphastar Pharmaceuticals Reports Q3 Earnings Beat on Revenue and EPS
Amphastar Pharmaceuticals (AMPH) reported third-quarter financial results that exceeded market expectations. The company posted a Non-GAAP earnings per share (EPS) of $1.14, surpassing analyst estimates by $0.28. Total revenue for the quarter reached $207.6 million, representing an 8.2% increase year-over-year and beating consensus estimates by $10.1 million. The results indicate steady top-line growth and improved profitability compared to previous periods.
Tickers: $AMPH
Topics: earnings beat EPS surprise revenue growth